Call Number (LC) Title Results
RC271.P43 P7574 1999 Proceedings of optical methods for tumor treatment and detection mechanisms and techniques in photodynamic therapy VIII : 23-24 January 1999, San Jose, California / 1
RC271.P43 P758 1999 Proceedings of photochemotherapy of cancer and other diseases 9-11 September 1998, Stockholm, Sweden / 1
RC271.P43 P759 1996 Proceedings of photochemotherapy photodynamic therapy and other modalities II : 7-8 September 1996, Vienna, Austria / 1
RC271.P43 P7592 1997 Proceedings of photochemotherapy photodynamic therapy and other modalities III : 4-6 September 1997, San Remo, Italy / 1
RC271.P43 P76 1990 Proceedings of photodynamic therapy--mechanisms II 16-17 January 1990, Los Angeles, California / 1
RC271.P43 P764 1995 Proceedings of photodynamic therapy of cancer II 9-20 September 1994, Lille, France / 1
RC271.P43 P774 Proceedings of photochemotherapy. 1
RC271.P43 P776 1999 Proceedings of photochemotherapy of cancer and other diseases : 9-11 September 1998, Stockholm, Sweden / 1
RC271.P43 R47 2015eb Resistance to photodynamic therapy in cancer / 1
RC271.P43 S45 1993 Selected papers on photodynamic therapy / 1
RC271.P43 W67 2009 Photodynamic therapy back to the future : 12th World Congress of the International Photodynamic Association : 11-15 June 2009, Seattle, Washington, United States / 1
RC271.P44 Exercise oncology prescribing physical activity before and after a cancer diagnosis /
Physical therapy and research in patients with cancer / 		2
RC271.P44 E94 2013 Exercise, energy balance, and cancer / 1
RC271.P44 E947 2010 Exercise and cancer survivorship impact on health outcomes and quality of life / 1
RC271.P44 P49 2011 Physical activity and cancer 1
RC271.P44 S78 2015eb Sports and exercise training as therapy in cancer : the impact on the 24 most common and deadliest cancer diseases worldwide / 1
RC271.P74 Resistance to proteasome inhibitors in cancer : molecular mechanisms and strategies to overcome resistance / 1
RC271.P74 R44 2006eb Regulation of carcinogenesis, angiogenesis and metastasis by the proprotein convertases (PCs) a new potential strategy in cancer therapy / 1
RC271.P76 Resistance to tyrosine kinase inhibitors
Protein kinase inhibitors as sensitizing agents for chemotherapy / 		2
RC271.P76 C67 2024 Molecules engineered against oncogenic proteins and cancer / 1